
A Collaborative Partnership must serve the ultimate purpose of improving patient and public health and welfare but will generally have no immediate direct benefit to Boehringer Ingelheim´s business objectives, and must not serve a specific Boehringer Ingelheim commercial promotional purpose (e.g. advertising opportunities). Boehringer Ingelheim cannot solely and disproportionately influence outcomes or hold the External Funding Recipient accountable for achieving a specific outcome (as would be the case in fee-for-service arrangements).In general, Boehringer Ingelheim may not request to be the sole funder of an External Funding Recipient or any of its major programs.
< Back to Medical Education Grant Overview